Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 20 Carcinoma, Non-Small-Cell Lung 18 Neoplasms 10 Adenocarcinoma 8 Neoplasm Metastasis 7 Colorectal Neoplasms 7 Carcinoma, Hepatocellular 6 Esophageal Neoplasms 5 Carcinoma, Renal Cell 5 Breast Neoplasms 5 Colonic Neoplasms 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Melanoma 3 Liver Neoplasms 3 Biliary Tract Neoplasms 3 Ureteral Neoplasms 2 Solid Tumors 2 Sarcoma 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Non-small Cell Lung Cancer Metastatic 2 Malignant Solid Tumor 2 Lung Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Transitional Cell 2 Solid Tumor 1 Solid Cancer 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1

Interventions

tusamitamab ravtansine 1 Ramucirumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Adenocarcinoma Gastric × Ramucirumab × Clear all

NCT05071053 2025-08-22

CARMEN-GC01

Sanofi

Phase 2 Terminated

35 enrolled 14 charts

Gastrointestinal

Adenocarcinoma Gastric

Data powered by HemOnc (CC BY 4.0) Colophon ⚡